Autor: admin


  • IRAD 04/05/2026

    Concesión de Becas IRAD-FEOR 2024 (Colaboración SEOR)

    Beca IRAD-FEOR · Con la colaboración de SEOR Beca IRAD-FEOR concedida a Pedro Prada Gómez Proyecto seleccionado en el marco de la Beca IRAD-FEOR con la colaboración de SEOR. Datos de la concesión InvestigadorPedro Prada Gómez CentroUniversidad de Cantabria ColaboraciónSEOR Proyecto concedido Estudio de la optimización de dosis de radioterapia para cáncer de mama, evitando […]
    Leer más
  • IRAD 04/05/2026

    IRAD-FEOR Grant Award 2024 – Pedro Prada Gómez (SEOR collaboration)

    IRAD-FEOR Grant · With the collaboration of SEOR IRAD-FEOR grant awarded to Pedro Prada Gómez Project selected under the IRAD-FEOR Grant with the collaboration of SEOR. Award details InvestigadorPedro Prada Gómez CentreUniversidad de Cantabria CollaborationSEOR Awarded project Study on the optimisation of radiotherapy dose for breast cancer, avoiding cardiac fibrosis in a human model of […]
    Leer más
  • IRAD 04/05/2026

    IRAD PI Regulations

    Normativa IRAD-FEOR Regulations for PIs with active funded projects IRAD-FEOR approves new regulations aimed at principal investigators with active funded projects. New monitoring and management framework IRAD-FEOR has approved, at the IRAD Governing Board, new regulations aimed at principal investigators with active funded projects. The initiative forms part of the work that IRAD, as a […]
    Leer más
  • IRAD 04/05/2026

    NORMATIVA IP’s IRAD

    Normativa IRAD-FEOR Normativa para los IPs con proyectos becados activos IRAD-FEOR aprueba una nueva normativa dirigida a los investigadores principales con proyectos becados activos. Nuevo marco de seguimiento y gestión IRAD-FEOR ha aprobado, en Junta de Gobierno de IRAD, una nueva normativa dirigida a los investigadores principales con proyectos becados activos. La iniciativa forma parte […]
    Leer más
  • IRAD 04/05/2026

    URONCOR 06-24

    URONCOR 06-24 Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer Short Versus Long-term Androgen Deprivation Therapy Combined With Salvage Radiotherapy in Prostate Cancer Patients With Biochemical Recurrence After Prostatectomy: a Multicentre Phase III Randomised Controlled Trial. NCT NumberNCT05781217 StatusRecruiting Study typeInterventional FasePhase 3 Participants534 Study record Short title Short Versus Long-term […]
    Leer más
  • IRAD 04/05/2026

    START-MET HS Prostate Cancer

    START-MET HS Prostate Cancer SbrT & Androgen Receptor Therapy METastatic HSPC Phase III Study of Stereotactic Body Radiation Therapy (SBRT) Plus Standard of Care in Castration Sensitive Oligometastatic Prostate Cancer Patients. NCT Number: NCT05209243 Status: Reclutando Study type: Intervencional Participants: 266 Study record Short title START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy […]
    Leer más
  • IRAD 04/05/2026

    IRAD Connect

    IRAD-FEOR Grant · With the collaboration of SEOR A brief, useful and highly focused meeting point A direct meeting space to share projects, research ideas, ongoing studies and possible collaborations with IRAD. What is IRAD Connect? Within the framework of the SEOR 2026 Congress, IRAD will have its own space under the name SEOR RESEARCH: […]
    Leer más
  • IRAD 04/05/2026

    LAB AECC 2025

    Other research grants LAB AECC 2025 Grant aimed at supporting emerging groups to consolidate their lines of cancer research through high-quality projects with a clear translational focus. Application period14/11/2024 – 23/01/2025 Closing time03:00 pm StatusAbierta We support emerging groups in consolidating their lines of cancer research by awarding financial grants to high-quality projects with a […]
    Leer más
  • IRAD 04/05/2026

    GUARD Consortium 25

    Other research grants GUARD Consortium Grants in Precision Medicine for Metastatic Bladder Cancer Call aimed at facilitating access to resources for independent clinical and/or translational research for researchers in genitourinary cancer. Application period13 March 2025 GUARD Consortium is pleased to announce the GUARD Consortium Grants in Precision Medicine for Metastatic Bladder Cancer, with the aim […]
    Leer más